Intelligent bio solutions signs south american distribution agreement with tscom for fingerprint drug screening system and secures first order

New york, july 06, 2023 (globe newswire) -- intelligent bio solutions inc. (nasdaq: inbs) (“inbs” or the “company”), a medical technology company developing and delivering intelligent, rapid, non-invasive testing solutions, today announced it has signed a distribution agreement for its intelligent fingerprinting drug screening system with chile-based company tscom spa, increasing the product's availability across south america. the company further announced it received its first order under this agreement, coming from a chile-based electrical distribution company.
INBS Ratings Summary
INBS Quant Ranking